Answer
No formal drug interaction studies have been conducted with Lemtrada (alemtuzumab) at the recommended dose in patients with multiple sclerosis.
Sources for this answer
- LEMTRADA 12 mg concentrate for solution for infusionSANOFI · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked